Clinical Study

A Randomized Phase III Trial Of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed By Weekly Paclitaxel With Or Without Carboplat

Posted Date: May 15, 2019

  • Investigator: Elizabeth Shaughnessy
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin. The addition of carboplatin to the usual chemotherapy could prevent your

Criteria:

To Be Eligible To Participate, Patients Must Have A Type Of Breast Cancer That Is Her2-Negative And

Keywords:

Triple Negative, Breast, Node Negative/Positi, Nrg-Br003, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.